PSYLO's Next Generation Psychedelic Pipeline: An Interview with CSO and Co-founder Sam Banister

psylo_news

13 Feb

Dr. Sam Banister – Drug Development, Biotech, and Exploring Non-Hallucinogenic Compounds (PT491)

Psylo

Psychedelic-inspired medicine to treat mental illness

We pay our respects to the Traditional Owners of the land on which we live and work.

KEEP IN TOUCH

Contact

Name

First Name

Last Name

Interest

Text Area

© 2022 PSYLO PTY LTD
All Rights Reserved.